FDA Eases Up On 'Smart Pills' For Wireless Monitoring

Law360, New York (May 15, 2013, 6:14 PM EDT) -- "Smart pills" — which are swallowed by patients and then send out health data in real time — won’t receive the U.S. Food and Drug Administration’s most stringent safety classification, an order set for publication Thursday said, potentially setting the stage for the technology to flourish.

The FDA’s order says that so-called ingestible event markers — tiny sensors that patients swallow along with their medicine — will be treated as Class II medical devices, as opposed to Class III varieties that face more difficult paths to...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.